Stocks making the biggest moves premarket: CrowdStrike, Rivian, Micron & more

Before the bell, Estée Lauder rose 3.5% after fiscal Q1 adjusted EPS of $0.72 and revenue of $3.72B beat estimates of $0.51 and $3.65B, respectively, and the company raised its full-year earnings outlook. Marvell agreed to acquire Lumentum in an all-stock deal valuing it at $115B, with closing expected in the first half of 2028; Marvell gained 3% and Lumentum rose 2% before trading was halted. CrowdStrike rose 3.4% and Rivian 3.8% after upgrades to buy, while memory stocks gained around 2% as traders appeared to rotate back into AI names.

Analysis

The actionable distinction is between fundamental catalysts and a positioning rebound. The CRWD upgrade’s AI-demand thesis is plausible, but an analyst view is not evidence of incremental contract value; near-term gains can reverse unless results show stronger security demand in bookings, retention, or remaining performance obligations. AI can also favor platform vendors: if buyers consolidate tools, PANW may capture spend even when the wider cybersecurity budget expands, so sympathy moves do not establish equal winners.

The memory rally looks most flow-sensitive: a bounce after a sharp sell-off does not establish a turn in pricing or inventory. Check company-specific mix, customer demand, and memory pricing before treating MU, SNDK, or WDC as interchangeable AI beneficiaries. For Rivian, the R2 ramp is an execution catalyst, not merely a valuation catalyst; timing, production, and cash use matter more than the upgrade. Estée Lauder’s beat and outlook raise are constructive, but sustainability depends on organic demand and margins, not the headline beat alone.

The Lumentum–Marvell deal presents the clearest event risk. An all-stock headline valuation is not cash proceeds: value to Lumentum holders moves with Marvell, while dilution, exchange terms, approvals, and a stated 2028 close leave a long period for deal risk and strategic execution to be repriced. The optical-component/silicon combination may broaden product capability, but integration and customer overlap need verification. Near term, the broad optimism is vulnerable to fading; over 6–18 months, reported execution and deal milestones matter more than today’s price action.

Key Decisions for Investors

• Treat CRWD’s upgrade-led move as a watch, not a standalone long. Add only if subsequent reporting confirms improving demand indicators; reduce the thesis if bookings or retention weaken. Do not infer PANW has the same near-term upside from sympathy trading.
• Do not chase the memory bounce. Reassess MU, SNDK, and WDC separately against pricing, inventory, and company-specific demand disclosures; a renewed deterioration in those indicators would falsify a durable recovery thesis.
• For Lumentum/Marvell, wait for definitive terms, exchange ratio, approvals, and unaffected trading prices before considering a ratio-adjusted long-Lumentum/short-Marvell deal spread. The long-dated expected close and stock consideration create material basis and break risk; the headline valuation alone is not an entry signal.
• For Rivian and Estée Lauder, keep the upgrade and earnings reactions on a catalyst watch: verify R2 production/ramp and cash-use milestones for Rivian, and organic sales and margin durability for Estée Lauder. Avoid extrapolating either headline into a sustained earnings upgrade without that confirmation.